Procter & Gamble (NYSE:PG) PT Raised to $186.00

Procter & Gamble (NYSE:PG) had its price objective raised by investment analysts at JPMorgan Chase & Co. from $179.00 to $186.00 in a report issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 6.76% from the stock’s previous close.

PG has been the subject of a number of other reports. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research report on Thursday, August 29th. BNP Paribas initiated coverage on Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price for the company. TD Cowen began coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price for the company. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Finally, Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price target for the stock from $182.00 to $175.00 in a research report on Wednesday, July 24th. Seven analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $176.16.

Procter & Gamble Trading Up 1.6 %

PG stock opened at $174.22 on Thursday. Procter & Gamble has a 1-year low of $141.45 and a 1-year high of $177.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market capitalization of $411.18 billion, a price-to-earnings ratio of 28.47, a PEG ratio of 3.84 and a beta of 0.41. The business has a 50 day simple moving average of $170.21 and a two-hundred day simple moving average of $165.69.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.37 EPS. Research analysts anticipate that Procter & Gamble will post 6.97 EPS for the current fiscal year.

Insider Activity

In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares in the company, valued at $3,657,210. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 375,553 shares of company stock worth $63,829,141. Company insiders own 0.17% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Large investors have recently modified their holdings of the business. HighPoint Advisor Group LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth about $17,696,000. Bayesian Capital Management LP grew its stake in shares of Procter & Gamble by 43.0% during the fourth quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock worth $7,743,000 after acquiring an additional 15,900 shares during the last quarter. Steele Capital Management Inc. acquired a new stake in shares of Procter & Gamble during the first quarter worth about $204,000. Gilbert & Cook Inc. lifted its holdings in shares of Procter & Gamble by 7.7% during the fourth quarter. Gilbert & Cook Inc. now owns 17,215 shares of the company’s stock worth $2,523,000 after purchasing an additional 1,237 shares during the period. Finally, Mosley Wealth Management acquired a new stake in shares of Procter & Gamble during the fourth quarter worth about $537,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.